Loading…
Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease
Saved in:
| Published in: | Biology of blood and marrow transplantation 2013-04, Vol.19 (4), p.676-677 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873 |
| container_end_page | 677 |
| container_issue | 4 |
| container_start_page | 676 |
| container_title | Biology of blood and marrow transplantation |
| container_volume | 19 |
| creator | Radhakrishnan, Kavita Bhatia, Monica Geyer, Mark B del Toro, Gustavo Jin, Zhezhen Baker, Courtney Harrison, Lauren Morris, Erin Baxter-Lowe, Lee Ann Cairo, Mitchell S |
| description | |
| doi_str_mv | 10.1016/j.bbmt.2013.02.002 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1319618430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1083879113000669</els_id><sourcerecordid>1319618430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhSMEoqXwAiyQlyyayzjOjyMhpDZQQKrEou3amtgT6lvHudhJUdn1zetwCwsWrMbSnHM0_k6Wveaw4cDrd9tN34_zpgAuNlBsAIon2SGvCpHXlaifpjdIkcum5QfZixi3ANCUsn2eHRSiBCFAHmb3p0tc3ID-mJ25xWDA3no6ZugNO3E0zsuvZcSedZM3draTt_777-WVD-RwJpNWwbBTN02GXQb0cefQz7hqmfWsu7bOBPLsp52v2YXVN45YR86xjzYSRnqZPRvQRXr1OI-yq7NPl92X_Pzb56_dyXmuy6qa876R2AiqaJAgwJjamJZTXbW8aoxs9SBlIWTPsZcGywZhqLBHAN4WrS5lI46yt_vcXZh-LBRnNdqo0yHoaVqi4oK3NZelgCQt9lIdphgDDWoX7IjhTnFQK3q1VSt6taJXUKiEPpnePOYv_Ujmr-UP6yR4vxdQ-uWtpaCituQ1GRtIz8pM9v_5H_6xa2e91ehu6I7idlqCT_wUVzEZ1MVa_to9F6n3um7FA_nWqso</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1319618430</pqid></control><display><type>article</type><title>Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Radhakrishnan, Kavita ; Bhatia, Monica ; Geyer, Mark B ; del Toro, Gustavo ; Jin, Zhezhen ; Baker, Courtney ; Harrison, Lauren ; Morris, Erin ; Baxter-Lowe, Lee Ann ; Cairo, Mitchell S</creator><creatorcontrib>Radhakrishnan, Kavita ; Bhatia, Monica ; Geyer, Mark B ; del Toro, Gustavo ; Jin, Zhezhen ; Baker, Courtney ; Harrison, Lauren ; Morris, Erin ; Baxter-Lowe, Lee Ann ; Cairo, Mitchell S</creatorcontrib><identifier>ISSN: 1083-8791</identifier><identifier>EISSN: 1523-6536</identifier><identifier>DOI: 10.1016/j.bbmt.2013.02.002</identifier><identifier>PMID: 23403308</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alemtuzumab ; Anemia, Sickle Cell - immunology ; Anemia, Sickle Cell - pathology ; Anemia, Sickle Cell - therapy ; Antibodies, Monoclonal, Humanized - therapeutic use ; Busulfan - therapeutic use ; Child ; Child, Preschool ; Cord Blood Stem Cell Transplantation ; Female ; Graft Rejection ; Graft Survival - drug effects ; Hematology, Oncology and Palliative Medicine ; Humans ; Infant ; Male ; Myeloablative Agonists - therapeutic use ; Transplantation Conditioning ; Unrelated Donors ; Vidarabine - analogs & derivatives ; Vidarabine - therapeutic use</subject><ispartof>Biology of blood and marrow transplantation, 2013-04, Vol.19 (4), p.676-677</ispartof><rights>American Society for Blood and Marrow Transplantation</rights><rights>2013 American Society for Blood and Marrow Transplantation</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873</citedby><cites>FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23403308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Radhakrishnan, Kavita</creatorcontrib><creatorcontrib>Bhatia, Monica</creatorcontrib><creatorcontrib>Geyer, Mark B</creatorcontrib><creatorcontrib>del Toro, Gustavo</creatorcontrib><creatorcontrib>Jin, Zhezhen</creatorcontrib><creatorcontrib>Baker, Courtney</creatorcontrib><creatorcontrib>Harrison, Lauren</creatorcontrib><creatorcontrib>Morris, Erin</creatorcontrib><creatorcontrib>Baxter-Lowe, Lee Ann</creatorcontrib><creatorcontrib>Cairo, Mitchell S</creatorcontrib><title>Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease</title><title>Biology of blood and marrow transplantation</title><addtitle>Biol Blood Marrow Transplant</addtitle><subject>Alemtuzumab</subject><subject>Anemia, Sickle Cell - immunology</subject><subject>Anemia, Sickle Cell - pathology</subject><subject>Anemia, Sickle Cell - therapy</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Busulfan - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cord Blood Stem Cell Transplantation</subject><subject>Female</subject><subject>Graft Rejection</subject><subject>Graft Survival - drug effects</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Myeloablative Agonists - therapeutic use</subject><subject>Transplantation Conditioning</subject><subject>Unrelated Donors</subject><subject>Vidarabine - analogs & derivatives</subject><subject>Vidarabine - therapeutic use</subject><issn>1083-8791</issn><issn>1523-6536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1TAQhSMEoqXwAiyQlyyayzjOjyMhpDZQQKrEou3amtgT6lvHudhJUdn1zetwCwsWrMbSnHM0_k6Wveaw4cDrd9tN34_zpgAuNlBsAIon2SGvCpHXlaifpjdIkcum5QfZixi3ANCUsn2eHRSiBCFAHmb3p0tc3ID-mJ25xWDA3no6ZugNO3E0zsuvZcSedZM3draTt_777-WVD-RwJpNWwbBTN02GXQb0cefQz7hqmfWsu7bOBPLsp52v2YXVN45YR86xjzYSRnqZPRvQRXr1OI-yq7NPl92X_Pzb56_dyXmuy6qa876R2AiqaJAgwJjamJZTXbW8aoxs9SBlIWTPsZcGywZhqLBHAN4WrS5lI46yt_vcXZh-LBRnNdqo0yHoaVqi4oK3NZelgCQt9lIdphgDDWoX7IjhTnFQK3q1VSt6taJXUKiEPpnePOYv_Ujmr-UP6yR4vxdQ-uWtpaCituQ1GRtIz8pM9v_5H_6xa2e91ehu6I7idlqCT_wUVzEZ1MVa_to9F6n3um7FA_nWqso</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Radhakrishnan, Kavita</creator><creator>Bhatia, Monica</creator><creator>Geyer, Mark B</creator><creator>del Toro, Gustavo</creator><creator>Jin, Zhezhen</creator><creator>Baker, Courtney</creator><creator>Harrison, Lauren</creator><creator>Morris, Erin</creator><creator>Baxter-Lowe, Lee Ann</creator><creator>Cairo, Mitchell S</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease</title><author>Radhakrishnan, Kavita ; Bhatia, Monica ; Geyer, Mark B ; del Toro, Gustavo ; Jin, Zhezhen ; Baker, Courtney ; Harrison, Lauren ; Morris, Erin ; Baxter-Lowe, Lee Ann ; Cairo, Mitchell S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Alemtuzumab</topic><topic>Anemia, Sickle Cell - immunology</topic><topic>Anemia, Sickle Cell - pathology</topic><topic>Anemia, Sickle Cell - therapy</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Busulfan - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cord Blood Stem Cell Transplantation</topic><topic>Female</topic><topic>Graft Rejection</topic><topic>Graft Survival - drug effects</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Myeloablative Agonists - therapeutic use</topic><topic>Transplantation Conditioning</topic><topic>Unrelated Donors</topic><topic>Vidarabine - analogs & derivatives</topic><topic>Vidarabine - therapeutic use</topic><toplevel>online_resources</toplevel><creatorcontrib>Radhakrishnan, Kavita</creatorcontrib><creatorcontrib>Bhatia, Monica</creatorcontrib><creatorcontrib>Geyer, Mark B</creatorcontrib><creatorcontrib>del Toro, Gustavo</creatorcontrib><creatorcontrib>Jin, Zhezhen</creatorcontrib><creatorcontrib>Baker, Courtney</creatorcontrib><creatorcontrib>Harrison, Lauren</creatorcontrib><creatorcontrib>Morris, Erin</creatorcontrib><creatorcontrib>Baxter-Lowe, Lee Ann</creatorcontrib><creatorcontrib>Cairo, Mitchell S</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biology of blood and marrow transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Radhakrishnan, Kavita</au><au>Bhatia, Monica</au><au>Geyer, Mark B</au><au>del Toro, Gustavo</au><au>Jin, Zhezhen</au><au>Baker, Courtney</au><au>Harrison, Lauren</au><au>Morris, Erin</au><au>Baxter-Lowe, Lee Ann</au><au>Cairo, Mitchell S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease</atitle><jtitle>Biology of blood and marrow transplantation</jtitle><addtitle>Biol Blood Marrow Transplant</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>19</volume><issue>4</issue><spage>676</spage><epage>677</epage><pages>676-677</pages><issn>1083-8791</issn><eissn>1523-6536</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23403308</pmid><doi>10.1016/j.bbmt.2013.02.002</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1083-8791 |
| ispartof | Biology of blood and marrow transplantation, 2013-04, Vol.19 (4), p.676-677 |
| issn | 1083-8791 1523-6536 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1319618430 |
| source | ScienceDirect Freedom Collection 2022-2024 |
| subjects | Alemtuzumab Anemia, Sickle Cell - immunology Anemia, Sickle Cell - pathology Anemia, Sickle Cell - therapy Antibodies, Monoclonal, Humanized - therapeutic use Busulfan - therapeutic use Child Child, Preschool Cord Blood Stem Cell Transplantation Female Graft Rejection Graft Survival - drug effects Hematology, Oncology and Palliative Medicine Humans Infant Male Myeloablative Agonists - therapeutic use Transplantation Conditioning Unrelated Donors Vidarabine - analogs & derivatives Vidarabine - therapeutic use |
| title | Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A13%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Busulfan,%20Fludarabine,%20and%20Alemtuzumab%20Conditioning%20and%20Unrelated%20Cord%20Blood%20Transplantation%20in%20Children%20with%20Sickle%20Cell%20Disease&rft.jtitle=Biology%20of%20blood%20and%20marrow%20transplantation&rft.au=Radhakrishnan,%20Kavita&rft.date=2013-04-01&rft.volume=19&rft.issue=4&rft.spage=676&rft.epage=677&rft.pages=676-677&rft.issn=1083-8791&rft.eissn=1523-6536&rft_id=info:doi/10.1016/j.bbmt.2013.02.002&rft_dat=%3Cproquest_cross%3E1319618430%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-b78a73e5ef8030dd6dd91e659157d89cf88238b1ab8da47a0f5aba001929c4873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1319618430&rft_id=info:pmid/23403308&rfr_iscdi=true |